申请人:Ono Pharmaceutical Co., Ltd.
公开号:US04320134A1
公开(公告)日:1982-03-16
The imidazole compounds of the general formula (I): ##STR1## wherein Y is a carboxyl group, a hydroxymethyl group, an N-di or -mono alkyl substituted or unsubstituted carbamoyl group, a cyano group, or an N-di or -mono alkyl substituted or unsubstituted aminomethyl group, and n is an integer of 3 to 20; and pharmaceutically acceptable salts thereof. These compounds have a strong inhibitory effect on thromboxane synthetase from rabbit platelet microsomes, and are useful as therapeutically active agents for inflammation, hypertension, thrombus, cerebral apoplexy and asthma.
通式(I)的咪唑化合物:其中Y是羧基、羟甲基基团、N-二烷基或-单烷基取代或未取代的氨甲酰基团、氰基,或N-二烷基或-单烷基取代或未取代的氨甲基基团,n为3至20的整数;和其药学上可接受的盐。这些化合物对兔血小板微粒体中的血栓素合成酶具有强烈的抑制作用,并可用作治疗活性剂,治疗炎症、高血压、血栓、脑卒中和哮喘。